ST Germain D J Co. Inc. Sells 172 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

ST Germain D J Co. Inc. trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.0% in the 4th quarter, Holdings Channel.com reports. The firm owned 17,084 shares of the healthcare conglomerate’s stock after selling 172 shares during the period. ST Germain D J Co. Inc.’s holdings in UnitedHealth Group were worth $8,642,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in UNH. Delta Financial Group Inc. grew its stake in shares of UnitedHealth Group by 1.0% in the third quarter. Delta Financial Group Inc. now owns 1,650 shares of the healthcare conglomerate’s stock worth $965,000 after acquiring an additional 17 shares during the last quarter. Fiduciary Group LLC increased its stake in UnitedHealth Group by 0.5% during the 2nd quarter. Fiduciary Group LLC now owns 3,695 shares of the healthcare conglomerate’s stock valued at $1,882,000 after purchasing an additional 18 shares in the last quarter. First PREMIER Bank lifted its stake in shares of UnitedHealth Group by 7.0% in the third quarter. First PREMIER Bank now owns 274 shares of the healthcare conglomerate’s stock worth $160,000 after buying an additional 18 shares in the last quarter. Genesee Capital Advisors LLC increased its position in shares of UnitedHealth Group by 1.9% during the third quarter. Genesee Capital Advisors LLC now owns 990 shares of the healthcare conglomerate’s stock valued at $579,000 after acquiring an additional 18 shares in the last quarter. Finally, Jmac Enterprises LLC boosted its stake in UnitedHealth Group by 2.2% during the 3rd quarter. Jmac Enterprises LLC now owns 823 shares of the healthcare conglomerate’s stock valued at $481,000 after purchasing an additional 18 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on UNH. Barclays upped their price target on UnitedHealth Group from $603.00 to $655.00 and gave the company an “overweight” rating in a report on Wednesday, November 27th. Morgan Stanley reduced their price target on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research note on Wednesday, October 16th. Piper Sandler dropped their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. TD Cowen raised their price target on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. Finally, Truist Financial lowered their target price on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a report on Monday. Two research analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, UnitedHealth Group has a consensus rating of “Buy” and a consensus target price of $626.79.

UnitedHealth Group Price Performance

UNH stock traded up $5.78 during mid-day trading on Friday, hitting $530.30. The company had a trading volume of 2,043,233 shares, compared to its average volume of 3,608,044. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The company has a market capitalization of $488.03 billion, a price-to-earnings ratio of 34.55, a P/E/G ratio of 1.53 and a beta of 0.62. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The company has a 50-day moving average price of $556.20 and a 200 day moving average price of $561.20.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. During the same period last year, the firm posted $6.56 earnings per share. UnitedHealth Group’s revenue for the quarter was up 9.2% compared to the same quarter last year. On average, research analysts anticipate that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were given a $2.10 dividend. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.58%. UnitedHealth Group’s dividend payout ratio is presently 54.72%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.